TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
TME Pharma signs exclusive agreement with TMS Co. for NOX-A12, targeting ~€10M upfront/near-term cash & shares for worldwide rights.
Covered in this story
Call it yourself
No calls on $TME yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Tencent Music Entertainment →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.